Clearly differentiating

1abtik pursues a strategy with an as early as possible, massive but short-acting inhibition of several critical pathways to attenuate the devastating hyper-inflammatory phase of these medical conditions. This approach enables the treatment of severe inflammations and allows the immune system to quickly return to normal, as required.

Such multi-target inhibition by highly potent, innovative compounds is a new, potentially game-changing approach.